Trend
DailyUptrend (starting)
4 hourBullish
1 hourLeaning Bearish
15 minBearish
5 minStrong Bullish
Daily trend turns down below $1.67
Key levels
Resistance$4.29
Resistance$4.06
Support$3.84
Support$3.55
Latest news & SEC filings
No headlines in the last 90 days.
Oramed Pharmaceuticals is a clinical-stage pharmaceutical company developing oral drug delivery technologies. Its lead product candidate is an oral insulin capsule for type 2 diabetes. The company also holds equity stakes in other biopharmaceutical companies and investments in real estate. It operates in Israel and the United States.
Based on the company's 10-K filed Mar 26, 2026.
Nasdaq · Healthcare
SEPT Low Target
$0.00
SEPT Mid Target
$0.00
SEPT High Target
$0.00
Analyst Consensus
$0.00
Thesis
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ORMP.
Start Free Trial →Valuation Verdict
UNDERVALUED
Methods Used
P/E Forward, P/B, PEG
Fair Value
$46.25
47
Moat Score
NARROW
3/9
Piotroski Score
N/A
Altman Z-Score
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
ACCUMULATING
Short Squeeze Risk
LOW
Signal: NEUTRAL
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| KIDRON NADAV | director officer | Buy | 349,497 | - | Sep 24, 2026 |
| KIDRON NADAV | director officer | Buy | 368,765 | - | Sep 24, 2026 |
| Hexter Joshua | officer | Buy | 75,455 | - | Sep 24, 2026 |
| Hexter Joshua | officer | Buy | 209,291 | - | Sep 24, 2026 |
| Kidron Miriam | director officer | Buy | 208,125 | - | Sep 24, 2026 |
| Kidron Miriam | director officer | Buy | 209,291 | - | Sep 24, 2026 |
| Gabay Avraham | officer | Buy | 209,291 | - | Sep 24, 2026 |
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →Revenue YoY
49.3%
3yr Revenue CAGR
N/A%
EPS Growth YoY
412.5%
FCF Growth YoY
-8.6%
Revenue Trend
ACCELERATING
SEPT Investing tracks real-time dark pool institutional trades for ORMP, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 15:26:40 | $4.00 | 2,250 | $$9K | BUY |
| 14:32:54 | $4.22 | 5,000 | $$21K | SELL |
| 21:01:46 | $4.13 | 1,411 | $$6K | SELL |
| 20:59:48 | $4.12 | 3,200 | $$13K | MIDPOINT |
| 20:59:48 | $4.12 | 2,800 | $$12K | MIDPOINT |
5 dark pool trades shown · $$61K preview volume
Real-time institutional flow, block trades, and net positioning
SEPT's Trading AI has generated a free, downloadable PDF research report for ORAMED PHARMACEUTICALS INC. (ORMP) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ORAMED PHARMACEUTICALS INC. (ORMP) is at $4.05, down 2.00% (-$0.08) at the Nov 12, 2026 close.
ORMP last reported on Aug 13, 2026: EPS $2.76 vs $0.43 expected — a beat of 541.9%.
ORMP trades at a P/E of 2.8.
Yes. ORMP's dividend yield is 9.21%.
Support: $3.84, $3.55, $3.36. Resistance: $4.06, $4.29, $4.58.
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.